<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04299854</url>
  </required_header>
  <id_info>
    <org_study_id>P/2019/469</org_study_id>
    <nct_id>NCT04299854</nct_id>
  </id_info>
  <brief_title>Modality of Induction of Labor in Obese Women at Term (MODOBAT)</brief_title>
  <acronym>MODOBAT</acronym>
  <official_title>Modalités de Déclenchement Des Patientes Obèses à Terme (MODOBAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hopital Nord Franche-Comte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <brief_summary>
    <textblock>
      In normal-weight patients, numerous studies show an equivalence of efficacy between&#xD;
      dinoprostone and balloon to induce labor. In obese patients, this efficacy is not known,&#xD;
      although inductions of labor are more frequent. MODOBAT aims to describe the ability to&#xD;
      obtain a vaginal delivery of two modality of induction of labor (vaginal dinoprostone and&#xD;
      single balloon Foley catheter) in obese women at term.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity has for several decades become a global epidemic in developed countries. In case of&#xD;
      pregnancy, obesity leads to an increased risk of obstetric complications, the indications of&#xD;
      induction of labor are then more frequent. Unfortunately the rate of failed induction is also&#xD;
      higher and therefore the risk of caesarean section is increased in obese women compared to&#xD;
      normal-weight patients when induction of labor is indicated. However, in this context&#xD;
      effectiveness of each mode of induction is not known. Some retrospective studies would&#xD;
      suggest that the balloon would be more effective because it would not be affected by the&#xD;
      increase in fat mass but this result are not , but the to confirm this hypothesis.&#xD;
&#xD;
      The aim of this study is to describe the caesarean section rate in induction of labor by&#xD;
      vaginal dinoprostone and single balloon Foley catheter in obese women. Patients in the&#xD;
      vaginal dinoprostone arm will be included retrospectively and patients in the single balloon&#xD;
      Foley catheter arm will be included prospectively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 11, 2020</start_date>
  <completion_date type="Actual">December 12, 2020</completion_date>
  <primary_completion_date type="Actual">December 12, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cesarean sections</measure>
    <time_frame>1 year</time_frame>
    <description>Rate of cesarean sections in each group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Entry into active phase (dilation to 5-6 cm)</measure>
    <time_frame>1 year</time_frame>
    <description>Rate of entry into active phase (dilation to 5-6 cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication</measure>
    <time_frame>1 year</time_frame>
    <description>Complication rate = composite criteria including :&#xD;
Hypercinesia / hypertonia rate&#xD;
Rate of fetal heart rate anomalies&#xD;
Fever rate during work&#xD;
Rate of uterine ruptures&#xD;
Postpartum hemorrhage rate&#xD;
Rate of infectious complications in immediate postpartum (fever&gt; 38.5 ° or wall abscess or endometritis defined by a fever greater than 38 ° with pain in uterine mobilization and foul or foul-smelling lochia)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">77</enrollment>
  <condition>Induction of Labor Affected Fetus / Newborn</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>Vaginal Dinoprostone</arm_group_label>
    <description>Induction of labor by 10mg of vaginal dinoprostone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single Balloon Foley Catheter</arm_group_label>
    <description>Induction of labor by single balloon Foley catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dinoprostone 10mg</intervention_name>
    <description>Vaginal delivery system containing 10mg of dinoprostone placed at the bottom of the vagina</description>
    <arm_group_label>Vaginal Dinoprostone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>single balloon Foley catheter</intervention_name>
    <description>A single balloon Foley catheter is being inserted on transcervical and inflated above the internal cervical os</description>
    <arm_group_label>Single Balloon Foley Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the level III maternity of university hospital center of Besançon and level IIB&#xD;
        maternity of regional hospital of Trevenans, France.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Medical indication of induction of labor&#xD;
&#xD;
          -  BMI ≥ 30 kg / m2&#xD;
&#xD;
          -  Bishop &lt; 6&#xD;
&#xD;
          -  Singleton&#xD;
&#xD;
          -  Gestational age &gt; 36 SA + 6j&#xD;
&#xD;
          -  Cephalic presentation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults under guardianship or curatorship&#xD;
&#xD;
          -  Scarred uterus&#xD;
&#xD;
          -  Placenta praevia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Nord Franche-Comté</name>
      <address>
        <city>Trévenans</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 5, 2020</study_first_submitted>
  <study_first_submitted_qc>March 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2020</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Induction of Labor</keyword>
  <keyword>BMI</keyword>
  <keyword>Obesity</keyword>
  <keyword>caesarean</keyword>
  <keyword>C-section</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Balloon</keyword>
  <keyword>Dinoprostone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

